Danish biotechnology entrepreneur
Christian Karsten Hansen (born 18 August 1966) is a Danish biotechnology entrepreneur, investor and inventor, with work in new drugs, molecular biology and biochemistry.
Personal background
Originally from
Copenhagen (Denmark), he spent his childhood in
Antwerp , Belgium and
Caracas , Venezuela before completing high school at
Sorø Academy in 1984. Following graduation as MSc chemical engineering from the
Technical University of Denmark in 1989,
[1] PhD work in molecular biology and biochemistry was conducted at the
Pasteur Institute ,
[2]
[3]
[4] France and the
University of Salamanca ,
[5] Spain. He also completed an MBA from the
Edinburgh Business School , Scotland.
[6]
Professional background
Hansen held positions as senior scientist and director of intellectual property management at
Novo Nordisk 1992–1999, and was a member of Enzyme Research Management.
[6] He co-founded one of the early Danish biotechnology companies,
Profound Pharma ,
[7]
[8] in 1999, with Jan Møller Mikkelsen,
[9] and remained co-CEO thereof until its acquisition by
Maxygen in 2000.
[10]
In 2001, he co-founded the investment firm Nordic Biotech Advisors,
[1]
[11] subsequently renamed NB Capital.
[12]
[13]
[14]
[15]
[16]
[17] [
excessive citations ] Also in 2001, he founded C Hansen Invest.
Since 2001, Hansen has co-founded and/or been a board member of numerous privately held and listed biotechnology companies including Osteologix,
[18]
[19] Nuevolution,
[15]
[20] Curalogic,
[6] Forward Pharma,
[21] Rose Pharma,
[22] Poalis,
[15] Aditech Pharma, Veloxis Pharmaceuticals,
[23] H Pharmaceuticals, Isar Pharma,
[24] and ParaTech.
[25]
Patents
Hansen has filed numerous patent applications in the fields of
genetics of bacteria,
cellulases and other
enzymes ,
osteoporosis , and
protein engineering and uses of
biopharmaceuticals . He is named as inventor of issued European patents 510091,
[26] 1250154,
[27] 1425304,
[28] 1534305,
[29] 1622629,
[30] 1622630,
[31] 1732575,
[32] 1745791
[33] 2266584
[34] and 2266585,
[35] and US patents 5,843,720,
[36] 5,916,796,
[37] 6,066,473,
[38] 6,555,660,
[39] 6,646,110,
[40] 6,831,158,
[41] 7,230,081,
[42] 7,232,562,
[43] 7,504,237,
[44] 7,550,565,
[45] 7,550,566,
[46] 7,595,342,
[47] 7,696,153
[48] and 8,541,471.
[49]
Various compounds from these companies and patents are in mid and late stages of clinical development.
[50]
[51]
[52]
[53]
References
^
a
b
"Festglad venturekapitalist – Diverse" . Business.dk. 10 November 2005. Retrieved 10 November 2011 .
^ Hansen, C K; Diderichsen, B; Jørgensen, P L (June 1992).
"celA from Bacillus lautus PL236 encodes a novel cellulose-binding endo-beta-1,4-glucanase" . Journal of Bacteriology . 174 (11): 3522–3531.
doi :
10.1128/jb.174.11.3522-3531.1992 .
PMC
206037 .
PMID
1592807 .
^ Jørgensen Per L., Hansen Christian K., Poulsen Gitte B., Diderichsen Børge (1990). "Gene : In vivo genetic engineering: homologous recombination as a tool for plasmid construction". Gene . 96 (1): 37–41.
doi :
10.1016/0378-1119(90)90338-R .
PMID
2265757 . {{
cite journal }}
: CS1 maint: multiple names: authors list (
link )
^ Jørgensen Per L., Hansen Christian K. (1990). "Gene : Multiple endo-β-1,4-glucanase-encoding genes from Bacillus lactus PL236 and characterization of the celB gene". Gene . 93 (1): 55–60.
doi :
10.1016/0378-1119(90)90135-E .
PMID
2227426 .
^ Hansen, Christian K. (1992).
"FEBS Letters : Fibronectin type III-like sequences and a new domain type in prokaryotic depolymerases with insoluble substrates" . FEBS Letters . 305 (2): 91–96.
doi :
10.1016/0014-5793(92)80871-D .
PMID
1618347 .
S2CID
33177292 .
^
a
b
c
"Archived copy" (PDF) . Archived from
the original (PDF) on 19 July 2011. Retrieved 17 January 2011 . {{
cite web }}
: CS1 maint: archived copy as title (
link )
^
"Rose Pharma – Board" . Gastrotechpharma.com. Archived from
the original on 21 November 2008. Retrieved 10 November 2011 .
^
"Speed, aggression, surprise!" . Mva.org. Archived from
the original on 28 July 2011. Retrieved 10 November 2011 .
^
"Dansk bioteks Lance Armstrong – Navne" . Business.dk. 3 August 2010. Retrieved 10 November 2011 .
^
"Maxygen Reports 2000 Third quarter Financial Results. – Free Online Library" . Thefreelibrary.com. Retrieved 10 November 2011 .
^
"Medicon Valley Patent Guide" (PDF) . Archived from
the original (PDF) on 27 July 2011. Retrieved 17 January 2011 .
^
"NB Capital" . NB Capital. Retrieved 10 November 2011 .
^
"Vækstfonden – Portefølje" . Vf.dk. Retrieved 10 November 2011 .
^
"European Biotechnology News :: Nordic biotech gets Euro41.5m fund" . Eurobiotechnews.eu. Archived from
the original on 20 July 2011. Retrieved 10 November 2011 .
^
a
b
c
"Danish venture capital company Nordic Biotech raises second biotech venture fund (in English)" . Mva.org. Archived from
the original on 11 September 2011. Retrieved 10 November 2011 .
^
"Discover Relevant Business Information" . venturebeatprofiles.com . Archived from
the original on 18 July 2012. Retrieved 17 January 2011 .
^ Christian Hansen PhD.
"NB Capital ApS: Private Company Information – BusinessWeek" . Investing.businessweek.com. Retrieved 10 November 2011 . [
dead link ]
^
"2005 Archives" . Osteologix. 29 November 2004. Retrieved 10 November 2011 .
^
"Archived copy" (PDF) . Archived from
the original (PDF) on 17 March 2012. Retrieved 17 January 2011 . {{
cite web }}
: CS1 maint: archived copy as title (
link )
^
"Biotech companies in Medicon Valley popular among investors – Invest in Denmark" . Investindk.com. 30 October 2007. Retrieved 10 November 2011 .
^
"Christian Hanse" . Forward-pharma.com. Archived from
the original on 11 July 2011. Retrieved 10 November 2011 .
^
"Rose Pharma" . Archived from
the original on 18 January 2011. Retrieved 14 January 2011 .
^
"Medicon Valley Financing Guide" (PDF) . Archived from
the original (PDF) on 27 June 2011. Retrieved 17 January 2011 .
^
"Isar Pharma K/S: News Release" . Marketwire.com. Retrieved 10 November 2011 .
^
"Board Members | ParaTech" . para-tech.dk . Archived from
the original on 28 July 2017. Retrieved 28 July 2017 .
^
"Espacenet – Bibliographic data" .
^
"espacenet – Bibliographic data" . V3.espacenet.com. 23 October 2002. Retrieved 10 November 2011 .
^
"espacenet – Bibliographic data" . V3.espacenet.com. 9 June 2004. Retrieved 10 November 2011 .
^
"espacenet – Original document" . V3.espacenet.com. Retrieved 10 November 2011 .
^
"Espacenet – Bibliographic data" .
^
"Espacenet – Bibliographic data" .
^
"espacenet – Bibliographic data" . V3.espacenet.com. 20 December 2006. Retrieved 10 November 2011 .
^
"Espacenet – Bibliographic data" .
^
"Espacenet – Bibliographic data" .
^
"Espacenet – Bibliographic data" .
^
"Introduction of DNA into bacillus strains by conjugation – US Patent 5843720 Description" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"Enzyme exhibiting cellulase activity – US Patent 5916796 Full Text" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"Introduction of DNA into bacillus strains by conjugation – US Patent 6066473 Description" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"G-CSF conjugates – US Patent 6555660 Full Text" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"G-CSF polypeptides and conjugates – US Patent 6646110 Full Text" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"G-CSF conjugates – US Patent 6831158 Full Text" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"Interferon gamma conjugates – US Patent 7230081 Full Text" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"E38N interferon gamma polypeptide variants – US Patent 7232562 Full Text" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"Polynucleotides encoding interferon gamma polypeptides – US Patent 7504237 Full Text" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"G-CSF conjugates – US Patent 7550565 Full Text" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"G-CSF conjugates – US Patent 7550566 Full Text" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions – US Patent 7595342 Full Text" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"G-CSF conjugates – US Patent 7696153 Full Text" . Patentstorm.us. Archived from
the original on 11 October 2012. Retrieved 10 November 2011 .
^
"Water-soluble strontium salts for use in treatment of cartilage and/Or bone conditions - US Patent 8541471 Full Text" . www.patentstorm.us . Archived from
the original on 27 September 2013. Retrieved 6 June 2022 .
^
"News" . Osteologix. 30 March 2009. Retrieved 10 November 2011 .
^ Clinical trial number
NCT00409032 for "A Dose-response Study With Strontium Malonate in Postmenopausal Women" at
ClinicalTrials.gov
^
"Treatment of Neutropenia, G-CSF, Neutrophils, Chemotherapy, Protein Therapeutics, Pegylated, Clinical Trial, Neupogen, Neulasta, Blood, Bone Marrow, Breast cancer, Lung cancer, Lymphomas, Leukemias" . Maxygen.com. Archived from
the original on 12 October 2011. Retrieved 10 November 2011 .
^ Clinical trial number
NCT00501332 for "Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy" at
ClinicalTrials.gov